Duration of previous treatment as a prognostic factor in metastatic colorectal cancer treated with trifluridine/tipiracil

We herein describe the findings from the trifluridine/tipiracil (TAS-102) Compassionate Use program in Latvia, set up prior to marketing authorization for the management of pretreated patients with metastatic colorectal cancer (mCRC). The efficacy and safety of TAS-102 in patients with refractory mC...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: Skuja, Elina, Gerina-Berzina, Aija, Hegmane, Alinta, Zvirbule, Zanete, Vecvagare, Eva, Purkalne, Gunta
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2018
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5920481/
https://ncbi.nlm.nih.gov/pubmed/29725539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1600
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker